Scientists probe link between cancer drugs, gut bugs, and hormones
NCT ID NCT05030038
Summary
This study aims to understand how a common breast cancer medication (an aromatase inhibitor) changes the bacteria in a patient's gut. Researchers will check stool and blood samples from 25 participants before starting the drug and again after 4 and 12 weeks of treatment. The goal is to see if changes in gut bacteria are linked to changes in hormone levels in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wake Forest Baptist Health Sciences
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.